A Randomized, Open-Label, Multi-Dose Crossover Study Assessing the Pharmacokinetic Profiles of Diazoxide Choline [diazoxide] Coated Versus Uncoated Formulations in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 01 Oct 2018
At a glance
- Drugs Diazoxide (Primary)
- Indications Prader-Willi syndrome
- Focus Pharmacokinetics
- 01 Oct 2018 Results from this study were presented at the 57th Annual European Society for Paediatric Endocrinology (ESPE).
- 08 Jan 2009 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
- 08 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.